Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

Completed · Phase 2

Conditions studied: Herpes Zoster, Neuralgia, Pain, HIV Infections, Peripheral Nervous System Diseases, Diabetic Neuropathies, Diabetes Mellitus, Polyneuropathies

In brief

This study is a randomized, open-label multi-center evaluation of the tolerability of treatment with NGX-4010 in conjunction with pre-patch topical application of one of three 4% lidocaine-based local anesthetic products. Eligible subjects will have moderate to severe neuropathic pain secondary to painful diabetic neuropathy (PDN), postherpetic neuralgia (PHN) or HIV-associated neuropathy (HIV-AN), with average numeric pain rating scale (NPRS) scores during screening of 3 to 8 (inclusive).

Key facts

Study ID

NCT00082316

Run by

NeurogesX

Last updated by the study team

2008-01-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NeurogesX Investigational Site — Huntsville, Alabama, United States
• NeurogesX Investigational Site — Mobile, Alabama, United States
• NeurogesX Investigational Site — Phoenix, Arizona, United States
• NeurogesX Investigational Site — Fountain Valley, California, United States
• NeurogesX Investigational Site — Los Gatos, California, United States
• NeurogesX Investigational Site — Denver, Colorado, United States
• NeurogesX Investigational Site — Clearwater, Florida, United States
• NeurogesX Investigational Site — New Port Richey, Florida, United States
• NeurogesX Investigational Site — North Miami, Florida, United States
• NeurogesX Investigational Site — Plantation, Florida, United States
• NeurogesX Investigational Site — West Des Moines, Iowa, United States
• NeurogesX Investigational Site — Wellesley Hills, Massachusetts, United States
• NeurogesX Investigational Site — St Louis, Missouri, United States
• NeurogesX Investigational Site — Greensboro, New Jersey, United States
• NeurogesX Investigational Site — Duncansville, Pennsylvania, United States
• NeurogesX Investigational Site — San Antonio, Texas, United States
• NeurogesX Investigational Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.